Development of [(18)F]AmBF(3) Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [(18)F]AmBF(3)-PEG(7)-Tyr(3)-Octreotide in an AR42J Pancreatic Carcinoma Model

[Image: see text] Radiolabeled peptides have emerged as highly specific agents for targeting receptors expressed in tumors for therapeutic and diagnostic purposes. Peptides developed for positron emission tomography (PET) are typically radiolabeled using prosthetic groups or bifunctional chelators f...

Descripción completa

Detalles Bibliográficos
Autores principales: Otaru, Sofia, Paulus, Andreas, Imlimthan, Surachet, Kuurne, Iida, Virtanen, Helena, Liljenbäck, Heidi, Tolvanen, Tuula, Auchynnikava, Tatsiana, Roivainen, Anne, Helariutta, Kerttuli, Sarparanta, Mirkka, Airaksinen, Anu J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305971/
https://www.ncbi.nlm.nih.gov/pubmed/35709482
http://dx.doi.org/10.1021/acs.bioconjchem.2c00231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305971/
https://www.ncbi.nlm.nih.gov/pubmed/35709482
http://dx.doi.org/10.1021/acs.bioconjchem.2c00231

Ejemplares similares